52 results
8-K
KALV
KalVista Pharmaceuticals Inc
7 Mar 24
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
6:38am
for a (i) base salary of $661,800 per year, subject to periodic review and (ii) annual bonus target equal to 60% of his base salary. In addition, pursuant … sum cash payment equal to 21 months of his base salary, (2) a lump sum payment equal to his full target bonus for the fiscal year in which
8-K
EX-1.1
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
in the Registration Statement, the Time of Sale Prospectus and the Prospectus. The descriptions of the Company’s stock option, stock bonus and other stock plans … or settlement of restricted stock units or performance-based restricted stock units, pursuant to any stock option, stock bonus or other stock plan
8-K
EX-10.1
KALV
KalVista Pharmaceuticals Inc
14 Jun 23
Departure of Directors or Certain Officers
4:30pm
. During the Term of Employment, the Executive shall have a target bonus opportunity under such plan or program equal to 50% of his current Base Salary … (the “Target Bonus”), based on satisfaction of performance criteria to be established by the Compensation Committee of the Board within the first
8-K
8da0jepsf 15xfq
14 Jun 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-1.1
oyja6t8wjum
11 Feb 21
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
4:18pm
8-K
zgb3kad
18 Dec 20
Departure of Directors or Certain Officers
4:05pm